Showing results (61-70 of 280) with videos related to
Sort By:
Pageof 28
Expert Opinion on Pharmacotherapy|October 11, 2014
Omacetaxine mepesuccinate in chronic myeloid leukemiaOmar Al Ustwani, Elizabeth A Griffiths, Eunice S Wang, et al.Plos Genetics|October 11, 2016
Epigenetics in Cancer: A Hematological PerspectiveMaximilian Stahl, Nathan Kohrman, Steven D Gore, et al.Clinical Advances in Hematology & Oncology : H&O|December 17, 2011
Early death in patients with acute promyelocytic leukemia. Proceedings from a live roundtable at the 2010 American Society of Hematology Annual Meeting, December 4–7, 2010, Orlando, FloridaMartin S Tallman, Francesco Lo-Coco, Hau C Kwaan, et al.Clinical Advances in Hematology & Oncology : H&O|March 3, 2012
Clinical roundtable monograph. Early death in patients with acute promyelocytic leukemiaMartin S Tallman, Francesco Lo-Coco, Hau C Kwaan, et al.Clinicoeconomics and Outcomes Research : CEOR|September 15, 2015
Acceptance of health technology assessment submissions with incremental cost-effectiveness ratios above the cost-effectiveness thresholdElizabeth A Griffiths, Janek K Hendrich, Samuel Dr Stoddart, et al.British Journal of Haematology|October 30, 2016
A phase 2 trial of high dose lenalidomide in patients with relapsed/refractory higher-risk myelodysplastic syndromes and acute myeloid leukaemia with trilineage dysplasiaAmer M Zeidan, B Douglas Smith, Hetty E Carraway, et al.Blood Reviews|December 29, 2015
Swallowing a bitter pill-oral arsenic trioxide for acute promyelocytic leukemiaPallawi Torka, Omar Al Ustwani, Meir Wetzler, et al.Cancers|September 28, 2021
Targeted Therapies for the Evolving Molecular Landscape of Acute Myeloid LeukemiaKhashayar Ahmadmehrabi, Ali R Haque, Ahmed Aleem, et al.Blood Reviews|January 4, 2015
How we will treat chronic myeloid leukemia in 2016Chetasi Talati, Evelena P Ontiveros, Elizabeth A Griffiths, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 16, 2017
The Role of Noncomparative Evidence in Health Technology Assessment DecisionsElizabeth A Griffiths, Richard Macaulay, Nirma K Vadlamudi, et al.Pageof 28